Cargando…
Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management
Public research and innovation initiatives in animal health aim to deliver key knowledge, services and products that improve the control of animal infectious diseases and animal welfare to deliver on global challenges including public health threats, environmental concerns and food security. The Tec...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811140/ https://www.ncbi.nlm.nih.gov/pubmed/36619962 http://dx.doi.org/10.3389/fvets.2022.1016959 |
_version_ | 1784863467064262656 |
---|---|
author | Arnouts, Sven Brown, Scott de Arriba, M. Luisa Donabedian, Michael Charlier, Johannes |
author_facet | Arnouts, Sven Brown, Scott de Arriba, M. Luisa Donabedian, Michael Charlier, Johannes |
author_sort | Arnouts, Sven |
collection | PubMed |
description | Public research and innovation initiatives in animal health aim to deliver key knowledge, services and products that improve the control of animal infectious diseases and animal welfare to deliver on global challenges including public health threats, environmental concerns and food security. The Technology Readiness Level (TRL) is a popular innovation policy instrument to monitor the maturity of upcoming new technologies in publicly funded research projects. However, while general definition of the 9 levels on the TRL-scale enable uniform discussions of technical maturity across different types of technology, these definitions are very generic which hampers concrete interpretation and application. Here, we aligned innovation pipeline stages as used in the animal health industry for the development of new vaccines or drugs with the TRL scale, resulting in TRL for animal health (TRLAH). This more bespoke scale can help to rationally allocate funding for animal health research from basic to applied research, map innovation processes, monitor progress and develop realistic progress expectations across the time span of a research and innovation project. The TRLAH thus become an interesting instrument to enhance the translation of public research results into industrial and societal innovation and foster public-private partnerships in animal health. |
format | Online Article Text |
id | pubmed-9811140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98111402023-01-05 Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management Arnouts, Sven Brown, Scott de Arriba, M. Luisa Donabedian, Michael Charlier, Johannes Front Vet Sci Veterinary Science Public research and innovation initiatives in animal health aim to deliver key knowledge, services and products that improve the control of animal infectious diseases and animal welfare to deliver on global challenges including public health threats, environmental concerns and food security. The Technology Readiness Level (TRL) is a popular innovation policy instrument to monitor the maturity of upcoming new technologies in publicly funded research projects. However, while general definition of the 9 levels on the TRL-scale enable uniform discussions of technical maturity across different types of technology, these definitions are very generic which hampers concrete interpretation and application. Here, we aligned innovation pipeline stages as used in the animal health industry for the development of new vaccines or drugs with the TRL scale, resulting in TRL for animal health (TRLAH). This more bespoke scale can help to rationally allocate funding for animal health research from basic to applied research, map innovation processes, monitor progress and develop realistic progress expectations across the time span of a research and innovation project. The TRLAH thus become an interesting instrument to enhance the translation of public research results into industrial and societal innovation and foster public-private partnerships in animal health. Frontiers Media S.A. 2022-12-21 /pmc/articles/PMC9811140/ /pubmed/36619962 http://dx.doi.org/10.3389/fvets.2022.1016959 Text en Copyright © 2022 Arnouts, Brown, de Arriba, Donabedian and Charlier. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Arnouts, Sven Brown, Scott de Arriba, M. Luisa Donabedian, Michael Charlier, Johannes Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management |
title | Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management |
title_full | Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management |
title_fullStr | Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management |
title_full_unstemmed | Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management |
title_short | Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management |
title_sort | technology readiness levels for vaccine and drug development in animal health: from discovery to life cycle management |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811140/ https://www.ncbi.nlm.nih.gov/pubmed/36619962 http://dx.doi.org/10.3389/fvets.2022.1016959 |
work_keys_str_mv | AT arnoutssven technologyreadinesslevelsforvaccineanddrugdevelopmentinanimalhealthfromdiscoverytolifecyclemanagement AT brownscott technologyreadinesslevelsforvaccineanddrugdevelopmentinanimalhealthfromdiscoverytolifecyclemanagement AT dearribamluisa technologyreadinesslevelsforvaccineanddrugdevelopmentinanimalhealthfromdiscoverytolifecyclemanagement AT donabedianmichael technologyreadinesslevelsforvaccineanddrugdevelopmentinanimalhealthfromdiscoverytolifecyclemanagement AT charlierjohannes technologyreadinesslevelsforvaccineanddrugdevelopmentinanimalhealthfromdiscoverytolifecyclemanagement |